American Kidney Stone Management, Ltd. – Trademark Portfolio
Entity Type: 16
American Kidney Stone Management, Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AKSM. The owner is based in Columbus, OH.
100 W. Third Ave. Ste 350
Columbus, OH 43201
Showing of trademarks Trademarks
Trademark Classifications
American Kidney Stone Management, Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does American Kidney Stone Management, Ltd. have?
American Kidney Stone Management, Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does American Kidney Stone Management, Ltd. file in?
American Kidney Stone Management, Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are American Kidney Stone Management, Ltd.'s most well-known trademarks?
American Kidney Stone Management, Ltd.'s registered trademark portfolio includes well-known marks such as AKSM. These are among 1 currently registered trademark in the portfolio.
What is American Kidney Stone Management, Ltd.'s trademark registration success rate?
American Kidney Stone Management, Ltd. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.